Indomethacin Treatment for Pericarditis
Indomethacin is NOT the preferred first-line NSAID for acute pericarditis—aspirin (750-1000 mg every 8 hours) or ibuprofen (600 mg every 8 hours) should be used instead, always combined with colchicine and gastroprotection. 1
Why Indomethacin is Not First-Line
The 2015 ESC Guidelines explicitly recommend aspirin or ibuprofen as first-line NSAIDs for acute pericarditis (Class I, Level A recommendation), with indomethacin notably absent from the acute pericarditis treatment table 1. Indomethacin only appears in the recurrent pericarditis dosing table, positioned as an alternative option rather than preferred therapy 1.
The choice between NSAIDs should be based on:
- Patient history (contraindications, previous efficacy/side effects)
- Concomitant diseases (favor aspirin if already needed for antiplatelet therapy)
- Physician expertise 1
When Indomethacin May Be Considered
For recurrent pericarditis, if aspirin or ibuprofen have failed or are not tolerated, indomethacin can be used at 25-50 mg every 8 hours (starting at the lower end to avoid headache and dizziness), with treatment duration of weeks to months and tapering by 25 mg every 1-2 weeks 1.
The FDA label supports dosing of 75-150 mg daily in 3-4 divided doses for inflammatory conditions, though this represents the broader range rather than the specific pericarditis recommendation 2. Research suggests 75-150 mg/day as a reasonable range 3.
Critical Dosing Considerations:
- Start low (25 mg three times daily) to minimize CNS side effects (headache, dizziness)
- Titrate upward only if needed
- Maximum 150-200 mg/day (though doses above 150 mg rarely increase effectiveness) 2
- Always provide gastroprotection 1
The Mandatory Combination: Colchicine
Regardless of which NSAID is chosen, colchicine MUST be added (Class I, Level A recommendation) 1:
- Dosing: 0.5 mg once daily if <70 kg OR 0.5 mg twice daily if ≥70 kg
- Duration: 3 months for first episode, at least 6 months for recurrent pericarditis 1
- Benefit: Reduces recurrence rate by approximately 50% (from 37.5% to 16.7%) 4
Alternative Therapies When NSAIDs Are Contraindicated
Second-Line: Low-Dose Corticosteroids
Use only when NSAIDs AND colchicine have failed or are contraindicated (Class IIa, Level C) 1:
- Dosing: Prednisone 0.2-0.5 mg/kg/day (NOT high doses of 1.0 mg/kg/day)
- Critical caveat: Corticosteroids increase recurrence risk and promote drug dependence—they should be added TO (not replace) NSAIDs/colchicine when possible 1
- Tapering: Extremely slow, especially below 10-15 mg/day threshold (decrease by 1.0-2.5 mg every 2-6 weeks) 1
Specific Indications for Corticosteroids:
- Autoimmune disease
- Pregnancy
- True NSAID allergy
- Recent peptic ulcer/GI bleeding
- High bleeding risk on anticoagulation 1
Third-Line: IL-1 Blockers
For multiple recurrent pericarditis refractory to NSAIDs, colchicine, and corticosteroids:
- Anakinra, rilonacept, or goflikicept
- Consider as second-line if contraindications to corticosteroids or high-risk features (multiple episodes, markedly elevated inflammatory markers) 4, 5
Treatment Algorithm
First-line: Aspirin 750-1000 mg q8h OR Ibuprofen 600 mg q8h
- PLUS colchicine (weight-adjusted)
- PLUS gastroprotection
- Duration: 1-2 weeks, guided by symptoms and CRP normalization
- Taper by 250-500 mg (aspirin) or 200-400 mg (ibuprofen) every 1-2 weeks 1
If first-line NSAIDs fail: Consider indomethacin 25-50 mg q8h
- Continue colchicine
- Same tapering principles
If NSAIDs contraindicated/failed: Add low-dose prednisone 0.2-0.5 mg/kg/day
- Keep colchicine
- Exclude infection first
- Very slow taper
Refractory recurrent cases: IL-1 blockers (anakinra)
Common Pitfalls to Avoid
- Never use corticosteroids as first-line—they triple recurrence risk 1
- Never omit colchicine—it's as important as the NSAID 1, 4
- Never taper too quickly—this is a major cause of recurrence 1
- Never continue treatment without monitoring CRP—use it to guide duration 1
- Never forget gastroprotection with any NSAID 1
Monitoring Strategy
- CRP levels: Guide treatment duration and assess response (Class IIa, Level C) 1
- Continue treatment until symptoms resolve AND CRP normalizes
- Taper only one drug class at a time 1
- Exercise restriction until symptom resolution, CRP normalization, and ECG/echo normalization (at least 3 months for athletes) 1